Latest Breaking News On - Ssuer fyb de000a1ewvy8 - Page 1 : comparemela.com

EQS-News: Formycon AG / Key word: Quarter Results/Quarterly / Interim Statement Formycon reports results for the first quarter 2023 30.05.2023 / 07:30 CET/CEST The issuer is. | May 30, 2023

United statesEnno spillnerTrademark of teva pharmaceutical industries ltdInternational financial reporting standardsGmbh coTrademark of genentech incFormycon groupTrademark of coherus biosciences incCorporate communicationsPress releaseCoherus biosciencesTeva pharmaceutical industriesManager corporate communicationsFormycon ag stock exchangePress releaseSsuer fyb de000a1ewvy8